ARDS

Acute Respiratory Distress Syndrome (ARDS)

Definition of ARDS

  • Acute Respiratory Distress Syndrome (ARDS) is characterized by:

    • Acute respiratory failure with specific criteria:

    • Hypoxemia despite the administration of 100% FiO2 (Fraction of Inspired Oxygen)

    • Decreased lung compliance

    • Dyspnea (difficulty breathing)

    • Non-cardiac pulmonary edema

    • Dense pulmonary infiltrates observed on X-ray, resembling "ground glass"


Other Terms Used

  • ARDS is also referred to as:

    • Noncardiogenic pulmonary edema

    • Adult respiratory distress syndrome

    • Shock lung

Occurrence

  • ARDS often occurs after an acute lung injury.

Prognosis

  • The prognosis is serious:

    • 50% mortality rate despite intensive interventions.

    • Outcomes can vary:

    • Patients may heal and recover.

    • Some may experience mild fibrosis and recover.

    • Others may develop severe fibrosis which can lead to death.

Risk Factors

  1. Direct pulmonary trauma:

    • Pulmonary contusion

    • Aspiration

    • Near drowning incidents

    • Fat emboli

    • Inhalation of toxins

    • Radiation exposure

    • Infectious pneumonia

  2. Indirect pulmonary trauma:

    • Sepsis

    • Shock

    • Disseminated Intravascular Coagulation (DIC)

    • Multi-system trauma

    • Pancreatitis

    • Coronary Artery Bypass Grafting (CABG)

    • Diabetic Ketoacidosis (DKA)

    • Multiple blood transfusions

Priority Action

  • Prevention through early recognition of patients at high risk for developing ARDS is critical.

    • Treatment should begin before overt symptoms appear.

    • Many patients present in surgical or medical units during the onset of ARDS symptoms.

Pathophysiology

  • Systemic inflammatory response leads to ARDS:

    • Major site of injury is the alveolar-capillary membrane.

    • Pathological changes can occur between 1 to 96 hours post-injury.

    • Patients may initially appear clinically stable with gradual or sudden onset of symptoms.

Disruption of Capillary Function
  • Lung injury disrupts normal capillary function, primarily due to poor perfusion to the alveoli:

    • Decreased perfusion can contribute to microemboli formation within pulmonary capillaries.

    • Release of histamine and inflammatory substances follows, causing dilation of pulmonary capillaries.

    • Capillary membrane leakage occurs, allowing proteins and plasma to escape into interstitial spaces, alveoli, and pleural space.

Plasma Leak
  • The leakage of plasma into the lungs is classified as non-cardiogenic pulmonary edema:

    • The heart remains functional; the edema results from vasodilation and damage to vessel membranes due to cytokines and histamine response.

Consequences of Hypoperfusion
  • Hypoperfusion of alveoli causes damage to Type II pneumocytes which produce surfactant:

    • This damage results in atelectasis (lung collapse).

    • As a result, fluid fills half of the alveoli, while the other half collapse, causing the lung tissue to become stiff and difficult to inflate.

Clinical Manifestations of ARDS

  • Common signs and symptoms include:

    • Tachypnea (increased respiratory rate)

    • Tachycardia (increased heart rate)

    • Restlessness

    • Increased work of breathing (the effort required for breathing)

    • Decreased lung expansion and compliance.

    • Breath sounds

    • Initially, abnormal breath sounds may not be present as edema begins in interstitial spaces, not airways.

    • In later stages, crackles and decreased breath sounds may occur.

    • Pulmonary edema evidenced by a pulmonary capillary wedge pressure (PCWP) that is low to normal.

Diagnostic Tests

  • Common diagnostic procedures:

    • Chest X-Ray (CXR): shows diffuse haziness or a "white out" appearance.

    • Arterial Blood Gas (ABG) analysis: reveals refractory hypoxemia despite high oxygen levels and may indicate respiratory and metabolic acidosis.

    • PCWP: typically requires a Swan-Ganz catheter and is usually low to normal.

Treatment Modalities

  • Respiratory support is critical.

    • Mechanical ventilation strategies:

    • Smaller tidal volumes with a more frequent rate (lung-protective ventilation)

    • Administer 100% FiO2 (with caution for oxygen toxicity)

    • Apply PEEP (Positive End-Expiratory Pressure) greater than 5 cm H2O to open collapsed alveoli and improve oxygenation (must monitor blood pressure and airway pressures).

Complications of PEEP
  • Potential complications include:

    • Decreased cardiac output due to increased intrathoracic pressure

    • Hypotension (low blood pressure)

    • Barotrauma (injury caused by increased pressure)

    • Necessity to assess lung sounds hourly, checking for pneumothorax, and monitoring increased intracranial pressure, especially in patients with head trauma or brain injury.

Monitoring Techniques
  • Utilize arterial lines to monitor blood pressure and obtain arterial blood samples.

  • Pulmonary artery catheters (Swan-Ganz) can evaluate blood volume, flow, and tissue oxygenation, with PCWP typically low to normal.

Treatment Strategies

  • Prone positioning is beneficial:

    • In the supine position, 60% of lung fields are dependent for fluid compared to 40% in the prone position.

    • Gravity causes fluid to collect in dependent lung fields when supine, leading to atelectasis and decreased gas exchange.

    • Prone positioning exposes more alveoli for ventilation and improves even distribution of tidal volume, enhancing lung compliance and secretions movement.

Specialty Beds for Proning
  • Options include:

    • RotoRest Bed

    • RotoProne Bed

    • Triadyne Bed

Pharmacologic Management
  • Key components:

    • Fluid management: Conservative, maintaining balance with diuretics.

    • Diuretics to treat alveolar and interstitial edema.

    • Antianxiety agents including Versed, fentanyl, Ativan, propofol.

    • Neuromuscular blocking agents (paralytics) such as Pavulon and Norcuron.

    • Antibiotics if an infection is present.

Continued Pharmacological Management
  • Steroids: Their effectiveness for ARDS remains controversial, but they may:

    • Stabilize cell membranes, reducing fluid leakage.

    • Decrease inflammation and aid in reducing fibrosis.

  • Vasopressors:

    • Commonly used agents include dopamine, Levophed.

Investigational Treatments
  • New treatment options under study:

    • Nitric oxide: dilates pulmonary blood vessels specifically within open, gas-exchanging alveoli.

    • Methylprednisolone infusion: aims to decrease lung inflammation.

    • Cytokines such as Interleukin-6 (IL-6) and TNF (Tumor Necrosis Factor) may help mitigate inflammatory responses in the lungs.

Other Investigational Treatments
  1. Surfactant replacement therapy

  2. Vitamins C and E: thought to decrease inflammation

  3. High-frequency jet ventilation

  4. ECMO (Extracorporeal Membrane Oxygenation):

    • Functions akin to a heart-lung bypass machine but is associated with complications like bleeding from heparin infusion and infection risks.

Nursing Management

  • Key nursing interventions focus on:

    • Assessment

    • Nutrition strategies

    • Positioning for optimal lung function (HOB elevation, prone positioning, specialty beds)

    • Pacing of activities to lessen oxygen consumption.

Specific Nursing Interventions
  • Interventions must aim at decreasing oxygen consumption:

    • Keeping fever controlled

    • Ensuring patients are not straining against the ventilator

    • Limiting movement, including turning in bed.

Nursing Diagnoses
  1. Ineffective airway clearance related to increased secretions.

  2. Ineffective gas exchange due to cellular debris and collapsed alveoli.

  3. Ineffective tissue oxygenation related to low blood volume and inadequate oxygenation.

    • Nursing interventions may include suctioning, turning every 2 hours, chest physiotherapy (CPT), providing humidity, and applying PEEP.

  4. Alteration in nutrition due to high caloric demands and the inability to consume oral foods.

    • Recommendations include tube feedings or Total Parenteral Nutrition (TPN) with low carbohydrates (to avoid increasing CO2) and high-calorie content.

  5. Risk for infection due to invasive lines and procedures, emphasizing sterile technique and handwashing adherence.

  6. Anxiety in families as a result of sudden illness onset, stressing the importance of family support, education, and communication.

Example Case Scenario

  • A patient diagnosed with ARDS has just been intubated and is on Assist-Control (AC) mechanical ventilation with parameters:

    • Rate: 16

    • FiO2: 80%

    • PEEP: 5 cm

    • Weight: 100 kg (ideal weight: 60)

  • Expected tidal volume setting: The tidal volume should be calculated based on ideal body weight, usually set at approximately 6-8 mL/kg.

  • High pressure alarm issues: The high-pressure alarm can be triggered by factors including:

    • Excess secretions or mucus plugging in the airways,

    • Coughing or patient movement,

    • Pneumothorax,

    • Equipment malfunction.